Reminder - Crown Crafts (CRWS) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 6/10/15, Crown Crafts, Inc. (CRWS) will trade ex-dividend, for its quarterly dividend of $0.08, payable on 7/2/15. As a percentage of CRWS's recent stock price of $8.09, this dividend works out to approximately 0.99%, so look for shares of Crown Crafts, Inc. to trade 0.99% lower — all else being equal — when CRWS shares open for trading on 6/10/15.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for CRWS, showing historical dividends prior to the most recent $0.08 declared by Crown Crafts, Inc.:

CRWS+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CRWS is likely to continue, and whether the current estimated yield of 3.96% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of CRWS shares, versus its 200 day moving average:

Crown Crafts, Inc. 200 Day Moving Average Chart

Looking at the chart above, CRWS's low point in its 52 week range is $7.07 per share, with $8.78 as the 52 week high point — that compares with a last trade of $8.05.

In Monday trading, Crown Crafts, Inc. shares are currently up about 0.5% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says